期刊文献+

PUMA基因对耐药绒癌化疗敏感性的影响 被引量:1

Effect of PUMA on sensitivity of drug resistant choriocarcinoma cells to chemotherapeutic agents
下载PDF
导出
摘要 目的研究p53上调凋亡调控因子(PUMA)对绒癌耐药细胞jeg-3/vp16化疗敏感性的影响。方法PUMA在化疗药物加入前用PUMA感染jeg-3/vp16细胞,观察抑制增殖的效应并探讨其机制。结果Ad-PUMA体内体外均显著增加耐药细胞对化疗药物的敏感性,增加化疗药物诱导绒癌细胞凋亡的能力。jeg-3/vp16的PUMA表达降低,而且对5-氟尿嘧啶(5-Fu)和依托泊苷(vp16)反应减弱。结论PUMA在化疗药物诱导凋亡的过程中发挥作用,Ad-PUMA与化疗药物合用后显著增加耐药绒癌细胞对化疗药物的敏感性。 Objective. To investigate the effect of PUMA on the sensitivity of drug-resistant choriocarcinoma cells to anticancer drugs. Methods: PUMA, carried by adenovirus (Ad-PUMA), was added into the culture medium of a drugresistant choriocarcinoma cell line jeg-3/vp16, before the chemotherapeutic agents 5-Fu, Vpl6 or MTX added. The effects and the mechanism of PUMA in vitro and in vivo were examined. Results. The cell proliferation was inhibited significantly when treated with combination of Ad-PUMA and the anticancer drugs, when compared to that treated with gnticancer drugs alone in vitro as well as in vivo. The apoptosis rate of the choriocarcinoma cells increased significantly when 5-Fu or Vp16 was combined with Ad-PUMA, observed from sub-G1 measurement and DAPI staining. PUMA was expressed lower in jeg-3/vp16 than in jeg-3, jeg-3/vpl6 responded much less sensitively to 5-Fu and vpl6 treatment than jeg-3, though PUMA was up-regulated in both cells. Conclusions. PUMA is a crucial factor in the apoptosis induced by anticancer drugs. Low dose of Ad- PUMA significantly restored the sensitivity of choriocarcinoma cells to chemotherapeutic agents in vitro and in vivo.
出处 《生殖医学杂志》 CAS 2008年第6期474-479,共6页 Journal of Reproductive Medicine
基金 国家自然科学基金资助项目(30572150) 北京市自然科学基金资助项目(7062043) 首都发展基金项目(2002-2008)
关键词 绒癌 耐药 凋亡 p53上调凋亡调控因子 Choriocarcinoma Drug resistance Apoptosis PUMA
  • 相关文献

参考文献10

  • 1Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53[J]. Mol Cell, 2001,7(3):683-694.
  • 2Partridge CS, Boden J, Lewis JC, et al. Choriocarcinoma xenografts in the nude rat[J]. Lab Anita, 1984,18(3):261-264.
  • 3Soussi T. The p53 pathway and human cancer[J]. Br J Surg, 2005,92(11): 1331-1332.
  • 4Jiang M, Wei Q, Wang J, et al. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis[J]. Oneogene, 2006,25(29) : 4056-4066.
  • 5Middelburg R, de Haas RR, Dekker H, et al. Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer [J]. Clin Cancer Res, 2005,11 (5): 1863-1869.
  • 6Wang X, Li M, Wang J, et al. The BH3-only protein, PUMA, is involved in oxaliplatin-indueed apoptosis in colon cancer cells [J]. Bioehem Pharmaeol, 2006,71(11) :1540-1550.
  • 7Yaginuma Y, Yamashita T, Takuma N, et al. Analysis of the p53 gene in human choriocarcinoma cell lines[J]. Br J Cancer, 1995,71(1) :9-12.
  • 8Yu J, Yue W, Wu B, et al. PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation[J]. Clin Cancer Res, 2006,12(9) :2928-2936.
  • 9Wang H, Qian H, Yu J, et al. Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugs[J]. Cancer Biol Ther, 2006,5 (4) : 380-385.
  • 10Karst AM, Dai DL, Martinka M, et al. PUMA expression is significantly reduced in human cutaneous melanomas[J]. Oncogene, 2005,24(6) : 1111-1116.

同被引文献50

  • 1江河,江孝清,周绪红,吴曙辉.喉鳞状细胞癌中PUMA、P53基因的表达及其临床意义[J].武汉大学学报(医学版),2006,27(1):57-59. 被引量:6
  • 2胡煜,张阳德,朱勤,彭健,潘一峰,王吉伟.PUMA在结肠癌细胞中的表达及诱导细胞凋亡中的作用[J].现代生物医学进展,2007,7(7):1058-1060. 被引量:3
  • 3Maher S, Toomey D, Condron C, Bouchier-Hayes D. Activation-induced cell death: the controver- sial role of Fas and Fas ligand in immune privi- lege and tumour counterattack. Immunol Cell Biol 2002; 80:131-137 :PMID: 11940113 DOI: 10.1046/ j.1440-1711.2002.01068.x].
  • 4Hug H. Fas-mediated apoptosis in tumor formation and defense. Biol Chem 1997; 378:1405-1412 [PMID: 9461339].
  • 5Bernstorff WV, Glickman JN, Odze RD, Farraye FA, Joo HG, Goedegebuure PS, Eberlein TJ. Fas (CD95/APO-1) and Fas ligand expression in nor- mal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer 2002; 94:2552-2560 [PMID: 12173320 DOI: 10.1002/ cncr.10549].
  • 6Yin F, Liu X, Li D, Wang Q, Zhang W, Li L. Tumor suppressor genes associated with drug resistance in ovarian cancer (Review). Oncol Rep 2013; 30:3-10 [PMID: 23660957 DOI: 10.3892/or.2013.2446].
  • 7Zahreddine H, Borden KL. Mechanisms and in- sights into drug resistance in cancer. Front Phar- macol 2013; 4:28 [PMID: 23504227 DOI: 10.3389/ fphar.2013.00028].
  • 8Lee EW, Seo J, Jeong M, Lee S, Song J. The roles of FADD in extrinsic apoptosis and necroptosis. BMB Rep 2012; 45:496-508 [PMID: 23010170 DOI: 10.5483/BMBRep.2012.45.9.186].
  • 9Guzzo MF, Carvalho LR, Bronstein MD. Apopto- sis: its role in pituitary development and neoplas- tic pituitary tissue. Pituitary 2013 Mar 20. [Epub ahead of print] [PMID: 23512699 DOI: 10.1007/ s11102-013-0481-5].
  • 10Zou XJ, Yang L, Yao SL. Endoplasmic reticulum stress and C/EBP homologous protein-induced Bax translocation are involved in angiotensin II-induced apoptosis in cultured neonatal rat cardiomyocytes. Exp Biol Med (Maywood) 2012; 237:1341-1349 [PMID: 23239445 DOI: 10.1258/ebm.2012.012041].

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部